Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients.

Seravalle G, Colombo M, Perego P, Giardini V, Volpe M, Dell'Oro R, Mancia G, Grassi G.

Hypertension. 2014 Aug;64(2):431-7. doi: 10.1161/HYPERTENSIONAHA.113.02988. Epub 2014 May 27.

2.

Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.

Grassi G, Seravalle G, Colombo M, Bolla G, Cattaneo BM, Cavagnini F, Mancia G.

Circulation. 1998 May 26;97(20):2037-42.

3.

Adrenergic and reflex abnormalities in obesity-related hypertension.

Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G.

Hypertension. 2000 Oct;36(4):538-42.

4.

Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension.

Grassi G, Turri C, Dell'Oro R, Stella ML, Bolla GB, Mancia G.

J Hypertens. 1998 Dec;16(12 Pt 1):1789-96.

PMID:
9869013
5.

Gender differences in sympathetic nervous activity: influence of body mass and blood pressure.

Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K, Schlaich M, Lambert G.

J Hypertens. 2007 Jul;25(7):1411-9.

PMID:
17563563
6.

Sympathetic activity and markers of cardiovascular risk in nondiabetic severely obese patients: the effect of the initial 10% weight loss.

Lambert EA, Rice T, Eikelis N, Straznicky NE, Lambert GW, Head GA, Hensman C, Schlaich MP, Dixon JB.

Am J Hypertens. 2014 Oct;27(10):1308-15. doi: 10.1093/ajh/hpu050. Epub 2014 Apr 9.

PMID:
24717419
7.

Sympathetic nerve activity and insulin in obese normotensive and hypertensive men.

Gudbjörnsdóttir S, Lönnroth P, Sverrisdóttir YB, Wallin BG, Elam M.

Hypertension. 1996 Feb;27(2):276-80. Erratum in: Hypertension 1996 Apr;27(4):1030.

8.

Longitudinal changes of blood pressure after weight loss: factors involved.

Flores L, Vidal J, Núñez I, Rueda S, Viaplana J, Esmatjes E.

Surg Obes Relat Dis. 2015 Jan-Feb;11(1):215-21. doi: 10.1016/j.soard.2014.04.028. Epub 2014 May 9.

PMID:
25304830
9.

Evidence for lower sympathetic nerve activity in young adults with low birth weight.

Weitz G, Deckert P, Heindl S, Struck J, Perras B, Dodt C.

J Hypertens. 2003 May;21(5):943-50.

PMID:
12714869
10.

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.

Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ.

J Clin Endocrinol Metab. 2005 Nov;90(11):5998-6005. Epub 2005 Aug 9.

PMID:
16091482
11.

Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly.

Grassi G, Seravalle G, Bertinieri G, Turri C, Dell'Oro R, Stella ML, Mancia G.

J Hypertens. 2000 May;18(5):587-93.

PMID:
10826562
12.

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study.

Grassi G, Seravalle G, Dell'Oro R, Trevano FQ, Bombelli M, Scopelliti F, Facchini A, Mancia G; CROSS Study.

J Hypertens. 2003 Sep;21(9):1761-9.

PMID:
12923410
13.

Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.

Dell'Oro R, Gronda E, Seravalle G, Costantino G, Alberti L, Baronio B, Staine T, Vanoli E, Mancia G, Grassi G.

J Hypertens. 2017 Dec;35(12):2532-2536. doi: 10.1097/HJH.0000000000001498.

14.

Baroreflex control of sympathetic nerve activity in essential and secondary hypertension.

Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G.

Hypertension. 1998 Jan;31(1):68-72.

15.
16.

Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension.

Grassi G, Seravalle G, Brambilla G, Pini C, Alimento M, Facchetti R, Spaziani D, Cuspidi C, Mancia G.

Int J Cardiol. 2014 Dec 20;177(3):1020-5. doi: 10.1016/j.ijcard.2014.09.138. Epub 2014 Oct 18.

PMID:
25449517
17.

Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives.

Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bombelli M, Cuspidi C, Facchetti R, Bolla G, Mancia G.

Hypertension. 2008 Nov;52(5):925-31. doi: 10.1161/HYPERTENSIONAHA.108.116368. Epub 2008 Sep 8.

18.

The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.

Straznicky NE, Grima MT, Eikelis N, Nestel PJ, Dawood T, Schlaich MP, Chopra R, Masuo K, Esler MD, Sari CI, Lambert GW, Lambert EA.

J Clin Endocrinol Metab. 2011 Mar;96(3):E503-8. doi: 10.1210/jc.2010-2204. Epub 2010 Dec 22.

PMID:
21177786
19.

Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.

Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Arenare F, Spaziani D, Mancia G.

Hypertension. 2009 Feb;53(2):205-9. doi: 10.1161/HYPERTENSIONAHA.108.121467. Epub 2009 Jan 5.

20.

Effects of hypertension and obesity on the sympathetic activation of heart failure patients.

Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bolla G, Mancia G.

Hypertension. 2003 Nov;42(5):873-7. Epub 2003 Oct 20.

Supplemental Content

Support Center